SweetBio Overview

  • Founded

  • 2015

Founded
  • Status

  • Private

  • Employees

  • 6

Employees
  • Latest Deal Type

  • Later Stage VC

  • (In Progress)
  • Investors

  • 9

SweetBio General Information

Description

Developer of therapeutic medical devices designed to provide wound care treatments. The company's services include developing honey-incorporated absorbable membranes that combine the benefits of multiple products, enabling medical practitioners to treat wounds with efficacy.

Contact Information

Website
www.sweetbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Primary Office
  • 460 South Highland Street
  • Memphis, TN 38111
  • United States
+1 (540) 000-0000

SweetBio Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SweetBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 05-Jan-2023 00.000 In Progress Generating Revenue
9. Later Stage VC 22-Apr-2022 Cancelled Generating Revenue
8. Later Stage VC 26-Aug-2021 00.000 Completed Generating Revenue
7. Seed Round 12-Jan-2021 000 00.000 0000 Completed Generating Revenue
6. Early Stage VC 11-Sep-2019 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2019 00.000 Completed Clinical Trials - General
4. Seed Round 13-Nov-2018 00.00 00.000 00.00 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2016 00.000 Completed Clinical Trials - General
2. Seed Round 01-Dec-2015 $1M $1.05M Completed Clinical Trials - General
1. Accelerator/Incubator 20-Apr-2015 $150K $50K Completed Startup
To view SweetBio’s complete valuation and funding history, request access »

SweetBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed 3 000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 2 000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1 185,000 $0.001000 $6.86 $6.86 1x $6.86 7.29%
To view SweetBio’s complete cap table history, request access »

SweetBio Executive Team (5)

Name Title Board Seat Contact Info
Isaac Rodriguez Ph.D Co- Founder, Chief Scientific Officer & Chief Executive Officer
Kayla Rodriguez Graff Co-Founder, Chief Executive Officer, Secretary & Board Member
Kevin Graff Co-Founder, Treasurer & Chief Financial Officer
You’re viewing 3 of 5 executive team members. Get the full list »

SweetBio Board Members (2)

Name Representing Role Since
Jan Bouten ZeroTo510 Board Member 000 0000
Kayla Rodriguez Graff SweetBio Co-Founder, Chief Executive Officer, Secretary & Board Member 000 0000
To view SweetBio’s complete board members history, request access »

SweetBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SweetBio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apple Corporation Minority 000 0000 000000 0
Launch Tennessee Not-For-Profit Venture Capital Minority 000 0000 000000 0
VamosVentures Venture Capital Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
The JumpFund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial